Not applicableActive Not RecruitingNCT06328647What this trial is testingQuantra Point-of-Care Hemostasis MonitoringWho this might be right forBleedingHemostatic Disorder The Cleveland Clinic 666
Not applicableStudy completedNCT01056978What this trial is testingPredictive Factors for Major Bleeding Risk in Patients Admitted in a Palliative Care UnitWho this might be right forHemorrhage Centre Hospitalier Universitaire de Saint Etienne 1,230
Large-scale testing (Phase 3)Ended earlyNCT01545635What this trial is testingRETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen PlasmaWho this might be right forMajor Trauma Medical University Innsbruck 100
Early research (Phase 1)Ended earlyNCT00376519What this trial is testingUmbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic DiseasesWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+3 more Masonic Cancer Center, University of Minnesota 3
Not applicableStudy completedNCT00296023What this trial is testingDonor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more University of California, San Francisco 25
Not applicableStudy completedNCT03820960What this trial is testingRisk Factors for Thrombosis in Immune ThrombocytopeniaWho this might be right forImmune Thrombocytopenia University Hospital, Toulouse 10,039
Not applicableNot Yet RecruitingNCT07173075What this trial is testingEvaluation of the Relationship Between Muscle Mass Measured by Bioelectrical Impedance Analysis and the Risk of Hemorrhagic Events Under Direct Oral Anticoagulants in the ElderlyWho this might be right forDirect Oral AnticoagulantHemmorhageElderly+3 more University Hospital, Clermont-Ferrand 110
Testing effectiveness (Phase 2)Ended earlyNCT00698685What this trial is testingPentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell TransplantationWho this might be right forLeukemiaLymphomaHodgkin's Disease+3 more University of Arizona 14
Not applicableStudy completedNCT01233921What this trial is testingPalifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+86 more Martin, Paul 6
Not applicableUnknownNCT05585944What this trial is testing" Effect of Single-nucleotide Polymorphism of CD40 Gene rs1883832 C/T on the Risk of Immune Thrombocytopenic Purpura "Who this might be right forImmune Thrombocytopenic Purpura Sohag University 80
Not applicableUnknownNCT02946866What this trial is testingCoHOrt of Cerebral CavernOus maLformATion: multicEnter Prospective Observational StudyWho this might be right forCerebral Cavernous MalformationIntracerebral Hemorrhage Seoul National University Hospital 228
Very early researchLooking for participantsNCT06398457What this trial is testingDarzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific AntibodiesWho this might be right forHematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Not applicableUnknownNCT04845555What this trial is testingAssociation Between Individual Clotting Factor Level Monitoring and the Risk of Bleeding Whilst Physical Active ConditionsWho this might be right forHemophilia A Prof. Dr. Dr. Thomas Hilberg 30
Early research (Phase 1)Ended earlyNCT00963495What this trial is testingStudy Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological MalignancyWho this might be right forAcute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+4 more University Health Network, Toronto 11
Not applicableStudy completedNCT03157154What this trial is testingBleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet TherapiesWho this might be right forHemophilia Nantes University Hospital 259
Not applicableLooking for participantsNCT05400824What this trial is testingMetabolic and Infectious Diseases in La Réunion (the REUNION Population-based Study)Who this might be right forInfectious DiseaseCardiovascular DiseasesGeneral Population+1 more Institut National de la Santé Et de la Recherche Médicale, France 2,000
Not applicableEnrolling By InvitationNCT07678619What this trial is testingSmart Analysis and Decision-Making for Emerging Infectious DiseasesWho this might be right forEmerging Infectious DiseasesCOVID-19Influenza+4 more Peking University 108
Testing effectiveness (Phase 2)Looking for participantsNCT07523555What this trial is testingAdaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic MalignanciesWho this might be right forRelapsed/Refractory B-cell Acute Lymphoblastic LeukemiaRelapsed/Refractory B-cell Non-Hodgkin Lymphoma or CLL/SLLRelapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia+4 more Beijing Biotech 96
Not applicableLooking for participantsNCT07358910What this trial is testingRisk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveWho this might be right forDengueChikungunyaZika Virus Infection+55 more Institut Pasteur du Cambodge 10,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT02861417What this trial is testingBusulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell TransplantWho this might be right forHematopoietic and Lymphoid Cell NeoplasmHigh Risk Acute Myeloid LeukemiaHigh Risk Myelodysplastic Syndrome+11 more M.D. Anderson Cancer Center 204